ID: ALA128883

Max Phase: Preclinical

Molecular Formula: C16H11NO5

Molecular Weight: 297.27

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(c1ccc(O)c(O)c1)c1nccc2cc(O)c(O)cc12

Standard InChI:  InChI=1S/C16H11NO5/c18-11-2-1-9(6-12(11)19)16(22)15-10-7-14(21)13(20)5-8(10)3-4-17-15/h1-7,18-21H

Standard InChI Key:  MXJOCCQOPDSMHV-UHFFFAOYSA-N

Associated Targets(Human)

Insulin-like growth factor binding protein 3 46 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 297.27Molecular Weight (Monoisotopic): 297.0637AlogP: 2.29#Rotatable Bonds: 2
Polar Surface Area: 110.88Molecular Species: NEUTRALHBA: 6HBD: 4
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 4#RO5 Violations (Lipinski): 0
CX Acidic pKa: 7.64CX Basic pKa: 3.86CX LogP: 2.38CX LogD: 2.16
Aromatic Rings: 3Heavy Atoms: 22QED Weighted: 0.43Np Likeness Score: 0.55

References

1. Chen C, Zhu YF, Liu XJ, Lu ZX, Xie Q, Ling N..  (2001)  Discovery of a series of nonpeptide small molecules that inhibit the binding of insulin-like growth factor (IGF) to IGF-binding proteins.,  44  (23): [PMID:11689087] [10.1021/jm010304b]

Source